Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Stem Cell Reviews and Reports|September 8, 2010
Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic miceN M Vieira, E Zucconi, C R Bueno, et al.
Biochemistry|March 30, 2019
Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBPBeth E Zucconi, Jessica L Makofske, David J Meyers, et al.
The Journal of Biological Chemistry|October 8, 2010
Alternatively expressed domains of AU-rich element RNA-binding protein 1 (AUF1) regulate RNA-binding affinity, RNA-induced protein oligomerization, and the local conformation of bound RNA ligandsBeth E Zucconi, Jeff D Ballin, Brandy Y Brewer, et al.
Biochemistry|June 23, 2016
Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112Beth E Zucconi, Birgit Luef, Wei Xu, et al.
The Journal of Biological Chemistry|December 3, 2014
A dimer interface mutation in glyceraldehyde-3-phosphate dehydrogenase regulates its binding to AU-rich RNAMichael R White, Mohd M Khan, Daniel Deredge, et al.
Cell Transplantation|November 22, 2012
Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophinN M Vieira, M Valadares, E Zucconi, et al.
Molecular Microbiology|December 20, 2014
Post-transcriptional regulation of transcript abundance by a conserved member of the tristetraprolin family in Candida albicansMelissa L Wells, Onica L Washington, Stephanie N Hicks, et al.
Neuromuscular Disorders : NMD|March 16, 2015
A normal life without muscle dystrophinM Zatz, N M Vieira, E Zucconi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2016
Cleavage and polyadenylation specificity factor 30: An RNA-binding zinc-finger protein with an unexpected 2Fe-2S clusterGeoffrey D Shimberg, Jamie L Michalek, Abdulafeez A Oluyadi, et al.
Cancer Research|March 27, 2019
MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human MelanomaEdward Kim, Beth E Zucconi, Muzhou Wu, et al.
Pageof 3